VIVAGEL Trademark

Trademark Overview

On Monday, March 27, 2006, a trademark application was filed for VIVAGEL with the United States Patent and Trademark Office. The USPTO has given the VIVAGEL trademark a serial number of 79029045. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Thursday, February 4, 2021. This trademark is owned by Starpharma Pty Limited. The VIVAGEL trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceuticals, pharmaceutical preparations, and drugs for medical purposes for treatment and prevention of [ viral, ] fungal and bacterial disease, namely, bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), human immunodeficiency virus (HIV)] ; [ chemical and biological preparations, ] substances for treatment and prevention of bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS) ] ; [ reagents and ] compounds for medical purposes; polyvalent compounds, synthetic molecules and dendrimers for medical purposes for treatment and prevention of bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS) ] ; antimicrobial preparations, namely, microbicidal preparations in the nature of g...

[ Contraceptive apparatus, namely, intravaginal cervical barriers; prophylactic instruments for use to prevent pregnancy and disease, namely, condoms, diaphragms, and intrauterine devices ]
vivagel

General Information

Serial Number79029045
Word MarkVIVAGEL
Filing DateMonday, March 27, 2006
Status709 - CANCELLED - SECTION 71
Status DateThursday, February 4, 2021
Registration Number3784858
Registration DateTuesday, May 4, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 16, 2010

Trademark Statements

Goods and ServicesPharmaceuticals, pharmaceutical preparations, and drugs for medical purposes for treatment and prevention of [ viral, ] fungal and bacterial disease, namely, bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), human immunodeficiency virus (HIV)] ; [ chemical and biological preparations, ] substances for treatment and prevention of bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS) ] ; [ reagents and ] compounds for medical purposes; polyvalent compounds, synthetic molecules and dendrimers for medical purposes for treatment and prevention of bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS) ] ; antimicrobial preparations, namely, microbicidal preparations in the nature of gels [, foams, creams, films, solutions, suppositories, suspensions and lotions ] for vaginal [, rectal and transdermal ] use for treatment and prevention of bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); contraceptives, namely, oral contraceptives, sponges, gels, foams, creams, films, solutions, suppositories, suspensions and lotions for use in preventing HIV and other sexually transmitted infections ] ; prophylactic preparations for prevention of [ pregnancy and ] disease; gels [, foams, creams, films, solutions, suppositories, suspensions and lotions, ] for the treatment of [ viral, fungal and ] bacterial diseases, namely, bacterial vaginosis [, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of human immunodeficiency virus ] ; vaginal gels [ and lubricants ] for the prevention of [ pregnancy and sexually transmitted infections and ] diseases of the human reproductive system
Pseudo MarkVIVA GEL
Goods and Services[ Contraceptive apparatus, namely, intravaginal cervical barriers; prophylactic instruments for use to prevent pregnancy and disease, namely, condoms, diaphragms, and intrauterine devices ]

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateThursday, February 4, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeG - NOT AVAILABLE
Class Status DateWednesday, May 25, 2016
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameStarpharma Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAU
Party NameStarpharma Pty Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU
Party NameStarpharma Pty Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events

Event DateEvent Description
Monday, March 20, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, December 28, 2022INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Friday, December 23, 2022GENERIC MADRID TRANSACTION SENT TO IB
Friday, December 23, 2022GENERIC MADRID TRANSACTION CREATED
Monday, October 4, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, February 4, 2021CANCELLED SECTION 71
Friday, June 7, 2019CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, April 26, 2019NEW REPRESENTATIVE AT IB RECEIVED
Saturday, October 6, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, March 16, 2018NOTIFICATION PROCESSED BY IB
Thursday, July 27, 2017NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 7, 2017PARTIAL INVALIDATION PROCESSED BY THE IB
Friday, June 9, 2017REFUSAL PROCESSED BY IB
Thursday, May 18, 2017NEW REPRESENTATIVE AT IB RECEIVED
Friday, May 5, 2017CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, April 28, 2017CORRECTION TRANSACTION RECEIVED FROM IB
Saturday, April 8, 2017GENERIC MADRID TRANSACTION SENT TO IB
Saturday, April 8, 2017GENERIC MADRID TRANSACTION CREATED
Friday, February 10, 2017NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, January 25, 2017PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, December 16, 2016NEW REPRESENTATIVE AT IB RECEIVED
Thursday, October 20, 2016INTERNATIONAL REGISTRATION RENEWED
Wednesday, May 25, 2016NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED
Wednesday, May 25, 2016REGISTERED - PARTIAL SEC 71 ACCEPTED
Friday, May 20, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 2, 2016TEAS SECTION 71 RECEIVED
Monday, May 2, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 5, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, August 12, 2010FINAL DISPOSITION NOTICE SENT TO IB
Thursday, August 12, 2010FINAL DISPOSITION PROCESSED
Wednesday, August 4, 2010FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 4, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, February 16, 2010PUBLISHED FOR OPPOSITION
Wednesday, January 27, 2010NOTICE OF PUBLICATION
Tuesday, January 12, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 29, 2009EXAMINERS AMENDMENT MAILED
Tuesday, December 29, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 29, 2009EXAMINER'S AMENDMENT ENTERED
Tuesday, December 29, 2009EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 16, 2009ASSIGNED TO EXAMINER
Tuesday, September 15, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 14, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 14, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 8, 2009NON-FINAL ACTION MAILED
Wednesday, July 8, 2009NON-FINAL ACTION WRITTEN
Friday, June 19, 2009SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Tuesday, December 2, 2008LETTER OF SUSPENSION MAILED
Monday, December 1, 2008SUSPENSION LETTER WRITTEN
Tuesday, November 11, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 11, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 11, 2008TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, September 25, 2008REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, September 25, 2008REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, July 22, 2008SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Thursday, April 10, 2008NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, March 27, 2008NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, March 27, 2008NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, March 13, 2008NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, January 9, 2008LETTER OF SUSPENSION MAILED
Wednesday, January 9, 2008SUSPENSION LETTER WRITTEN
Friday, December 14, 2007SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Tuesday, June 12, 2007LETTER OF SUSPENSION MAILED
Monday, June 11, 2007SUSPENSION LETTER WRITTEN
Thursday, May 24, 2007AMENDMENT FROM APPLICANT ENTERED
Thursday, May 24, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 24, 2007ASSIGNED TO LIE
Monday, May 7, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 7, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 24, 2006REFUSAL PROCESSED BY IB
Tuesday, November 7, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, November 7, 2006REFUSAL PROCESSED BY MPU
Saturday, November 4, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, November 3, 2006NON-FINAL ACTION WRITTEN
Friday, October 27, 2006ASSIGNED TO EXAMINER
Friday, October 27, 2006NEW APPLICATION ENTERED
Thursday, October 26, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

vivagel virus human bacterial namely preparations simplex papilloma acquired syndrome immunodeficiency